Pillstats
Rx only · Injection, Solution · Intravenous

Erythropoietin

Brands: Procrit · Epoetin

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US7 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)105694
US makers1 labelers
Packages8
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$98.35$196.70$295.05$393.39Jan 2025Mar 2026Jul 2026
$342.053
Latest avg · Jul 22, 2026
+426%
Since Jan 22, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

3.5K7.1K11K14K2025 Q12025 Q22025 Q32025 Q42026 Q1
9.5K
Rx · 2026 Q1
23K
Units dispensed
-5%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Janssen Products LPunknown8SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Sep 13, 2017
    RECALLRecall (Class II): Procrit (epoetin alfa), 10,000 units/mL, packaged in a) box of 6 single use 1 mL vials (NDC 59676-310-01), b) box of 25…

    Presence of particulate matter: glass flakes identified as lamellae observed during a routine quality inspection. — Recalling firm: Amgen, Inc. — U.S.A. Nationwide

  • Aug 4, 2017
    RECALLRecall (Class II): Procrit Epoetin Alfa 40,000 units/mL single use vial For Intravenouse or Subcutaneous Use Only, Rx only, Manufactured b…

    Presence of particulate matter: Visible glass flakes identified as lamellae in some drug product vials. — Recalling firm: Amgen, Inc. — United States including Puerto Rico